Mark S. Tichenor

596 total citations
14 papers, 455 citations indexed

About

Mark S. Tichenor is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Mark S. Tichenor has authored 14 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Organic Chemistry. Recurrent topics in Mark S. Tichenor's work include Cannabis and Cannabinoid Research (4 papers), Cancer therapeutics and mechanisms (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). Mark S. Tichenor is often cited by papers focused on Cannabis and Cannabinoid Research (4 papers), Cancer therapeutics and mechanisms (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). Mark S. Tichenor collaborates with scholars based in United States, Belgium and Italy. Mark S. Tichenor's co-authors include Dale L. Boger, David B. Kastrinsky, Inkyu Hwang, John D. Trzupek, J. M. O’Connor, Thomas J. Rayl, Karen S. MacMillan, Mark Seierstad, Sandra R. Chaplan and J. Guy Breitenbucher and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Mark S. Tichenor

13 papers receiving 450 citations

Peers

Mark S. Tichenor

PHARM

TOXIC

Karen S. MacMillan United States

Damien Habrant France

Faqin Jiang China

Hideyuki Sugiyama Japan

Vincent J. Colandrea United States

Ronald Wolin United States

Namballa Hari Krishna India

Andrew J. Eatherton United Kingdom

Balu Balasubramanian United States

Fuk‐Wah Sum United States

Karen S. MacMillan United States

Mark S. Tichenor

241 ×0.9

246 ×1.1

83 ×0.7

PHARM

27 ×0.6

TOXIC

27 ×0.8

Citations per year, relative to Mark S. Tichenor Mark S. Tichenor (= 1×) peers Karen S. MacMillan

Countries citing papers authored by Mark S. Tichenor

Since Specialization

Citations

This map shows the geographic impact of Mark S. Tichenor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Tichenor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Tichenor more than expected).

Fields of papers citing papers by Mark S. Tichenor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Tichenor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Tichenor. The network helps show where Mark S. Tichenor may publish in the future.

Co-authorship network of co-authors of Mark S. Tichenor

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Tichenor. A scholar is included among the top collaborators of Mark S. Tichenor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Tichenor. Mark S. Tichenor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Damm‐Ganamet, Kelly L., Clara Moon, Alan D. Wickenden, et al.. (2025). Allosteric modulation of the solute carrier transporter SLC39A8 potentiates manganese and cadmium uptake. Journal of Clinical Investigation. 135(21).

Seierstad, Mark, Mark S. Tichenor, Renée L. DesJarlais, et al.. (2021). Novel Reagent Space: Identifying Unorderable but Readily Synthesizable Building Blocks. ACS Medicinal Chemistry Letters. 12(11). 1853–1860. 7 indexed citations

Philippar, Ulrike, Lorena Fontán, Ivo Cornelissen, et al.. (2021). Abstract 1267: Combination therapy of JNJ-67856633, a novel, first-in-class MALT1 protease inhibitor, and JNJ-64264681, a novel BTK inhibitor, for the treatment of B-cell lymphomas. Cancer Research. 81(13_Supplement). 1267–1267. 2 indexed citations

Keith, John M., Mark S. Tichenor, Richard L. Apodaca, et al.. (2016). The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(13). 3109–3114. 11 indexed citations

Tichenor, Mark S., Robin L. Thurmond, Jennifer D. Venable, & Brad M. Savall. (2015). Functional Profiling of 2-Aminopyrimidine Histamine H₄Receptor Modulators. Journal of Medicinal Chemistry. 58(18). 7119–7127. 11 indexed citations

Keith, John M., W. M. Jones, Mark S. Tichenor, et al.. (2015). Preclinical Characterization of the FAAH Inhibitor JNJ-42165279. ACS Medicinal Chemistry Letters. 6(12). 1204–1208. 47 indexed citations

Tichenor, Mark S., John M. Keith, W. M. Jones, et al.. (2012). Heteroaryl urea inhibitors of fatty acid amide hydrolase: Structure–mutagenicity relationships for arylamine metabolites. Bioorganic & Medicinal Chemistry Letters. 22(24). 7357–7362. 20 indexed citations

Keith, John M., Richard L. Apodaca, Mark S. Tichenor, et al.. (2012). Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate. ACS Medicinal Chemistry Letters. 3(10). 823–827. 31 indexed citations

Tichenor, Mark S. & Dale L. Boger. (2007). Yatakemycin: total synthesis, DNA alkylation, and biological properties. Natural Product Reports. 25(2). 220–226. 65 indexed citations

10.

Tichenor, Mark S., Karen S. MacMillan, James S. Stover, et al.. (2007). Rational Design, Synthesis, and Evaluation of Key Analogues of CC-1065 and the Duocarmycins. Journal of the American Chemical Society. 129(45). 14092–14099. 31 indexed citations

11.

Tichenor, Mark S., Karen S. MacMillan, John D. Trzupek, et al.. (2007). Systematic Exploration of the Structural Features of Yatakemycin Impacting DNA Alkylation and Biological Activity. Journal of the American Chemical Society. 129(35). 10858–10869. 38 indexed citations

12.

Tichenor, Mark S., et al.. (2006). Asymmetric Total Synthesis of (+)- and ent-(−)-Yatakemycin and Duocarmycin SA: Evaluation of Yatakemycin Key Partial Structures and Its Unnatural Enantiomer. Journal of the American Chemical Society. 128(49). 15683–15696. 65 indexed citations

13.

Tichenor, Mark S., David B. Kastrinsky, & Dale L. Boger. (2004). Total Synthesis, Structure Revision, and Absolute Configuration of (+)-Yatakemycin. Journal of the American Chemical Society. 126(27). 8396–8398. 87 indexed citations

14.

O’Connor, J. M., et al.. (2002). Ruthenium-Mediated Cycloaromatization of Acyclic Enediynes and Dienynes at Ambient Temperature. Journal of the American Chemical Society. 124(14). 3506–3507. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact